Purpose: Beta-lactam antibiotics in combination with a beta-lactamase inhibitor are the first-26 line treatment option for Haemophilus influenzae infections. However, beta-lactamase-27 independent resistance to beta-lactams is increasing. This resistance mechanism has been 28 linked to amino acid substitutions in the penicillin-binding protein 3 (PBP3), but how these 29 substitutions lead to decreased binding affinities to certain beta-lactam antimicrobials 30 remains unknown. 31
antibiotics (13, 14) . Based on the beta-lactamase production and presence of ftsI mutations, 69 the strains can be classified into four susceptibility groups (Table 1a) as previously described  70 by Ubukata et al., . The strains with low-level 71 PBP3-mediated resistance such as group I and II (low-rPBP3) show ampicillin minimal 72 inhibitory concentrations (MICs) between 0.5 and 2 mg/L, whereas strains with high-level 73 resistance (high-rPBP3) such as group III exhibit higher ampicillin MICs between 1 and 16 74 mg/L, often combined with reduced susceptibility to cephalosporins (11, (17) (18) (19) (20) (21) (22) . Although 75 group III isolates are mainly distributed in some Asian countries such as Japan and Korea 76 (23, 24) , these more resistant strains, especially group III-like have been detected on rare 77 ocasions in some European countries (3, 14, 20, 25, 26) . 78
PBPs are transpeptidases or carboxypeptidases involved in peptidoglycan 79 metabolism. They harbour three specific motifs: SXXK, (S/Y)XN and (K/H) (S/T)G, which 80 define the active site of the serine penicillin-recognizing enzyme family (15, 27) . The serine in 81 the SXXK motif is crucial to the catalytic mechanism (27) . 82
The aim of our study was to investigate the impact of PBP3 amino acid substitutions 83 in clinical isolates of H. influenzae on (i) antimicrobial susceptibility, (ii) the beta-lactam 84 binding site based on published PBP3 crystal structures, and (iii) to investigate, whether 85 there is an association between antimicrobial susceptibility and the location of the substituted 86 amino acids. we found only two strains in this group. Since we were interested in beta-lactamase 127 independent resistance, all beta-lactamase producing strains were excluded as well. To 128 correct the obtained p-values for multiple hypothesis testing, we used the Hochberg-Yekutiely procedure that controls the false discovery rate (30). The analysis has 130 been done in R. All analysis scripts including raw data and figure-generating scripts are 131 available on gitlab: https://gitlab.com/csb.ethz/haemophilus-pbp3-manuscript (online 132 ressource ESM1). 133 134 Phenotypic and genotypic determination of beta-lactamase production 135 Beta-lactamase production was determined with BBL TM Cefinase TM Paper Discs (Beckton 136 Dickinson, Franklin Lakes, NJ, USA) according to manufacturer's instructions. Presence of 137 TEM-1 beta-lactamase encoding gene was determined by conventional PCR with primers 138 described by Dabernat et al. (16) . The following reference strains were used as controls for 139 Nucleic acid extraction was performed with Advanced XL EZ1 (Qiagen, Hilden, Germany). 144
The digestion step using proteinase K was performed for 10 minutes at 56 °C and 10 145 minutes at 95 °C followed by purification with EZ1 Tissue card according to the 146 manufacturer's protocol. DNA extracts were eluted in 100 μl elution buffer. Amplification of 147 ftsI gene was performed by using the conventional PCR assay described by Cerquetti et al. 148 (31) . PCR products were purified with ExoSAP-IT® (USB Corporation, Cleveland, OH, USA) 149 purification kit. The sequencing of the PCR amplicon was performed by Microsynth AG 150 (Balgach, Switzerland) using Sanger sequencing (sequencing primer frw : 5'-151 
Results

180
Identification of PBP3 amino acid substitution groups 181
Based on the PBP3 amino acid sequence deduced from the ftsI gene sequence, we 182 assigned the investigated strains (n=53) to following groups as previously described (Table  183 1b): wild type (n=17), group I (n=2), group II (a, b and d; n=21) or group M (miscellaneous, 184 n=13) ( Asp350Asn and Val547Ile and Asn569Ser) were described previously by Cherkaoui et al. 187 (14, 33) . The remaining substitution combinations in group M have been identified for the first 188 time in four strains of this study ( Table 2) . 189 190
MICs for beta-lactam antibiotics of different PBP3 amino acid substitution groups 191
All determined MICs are summarized in Table 3 and shown in Figure 1 . All strains with 192 amino acid substitutions in PBP3 belonging to groups I, II and M (beta-lactamase producers 193 excluded) showed very low MICs for piperacillin and piperacillin-tazobactam (range 0.016-194 0.25 and <0.016-0.25 mg/l, respectively), which was not observed for any other penicillin with 195 or without beta-lactamase inhibitor ( Table 3 and Figure S1 ). For all tested antimicrobials, we 196 compared the MICs of group IIa, IIb, IId and group M isolates (beta-lactamse producers 197 excluded) to the respective MICs of the wildtype. Group I isolates have been excluded due to 198 low sample size (n=2). We found no significant difference between group M and the wild type 199 isolates. In contrast, all group II isolates showed significantly higher MICs (p-values ranging 200 from 0.007 to 0.016, see Figure 1 ) except for piperacillin and piperacillin-tazobactam. 201
202
In the benzylpenicillin disc screen, all wild type and group M isolates (except beta-lactamase 203 producing strains) were categorized as beta-lactam susceptible (Figure S2 ). All group I and 204 group II isolates were categorized as resistant in the beta-lactamase screen (zone diameter 205 <=11mm), except for two strains with zone diameters of 12 mm (on the breakpoint) which 206 were categorized as susceptible. 207 208 Impact of group-specific amino acid substitutions on the PBP3 crystal structure 209
We investigated the position of the identified group-specific amino acid substitutions and their 210 impact on the PBP3 binding site (Figure 2) . Since there was no PBP3 crystal structure of H. 211 influenzae available at the time of this study, we selected PBP3 crystal structures from E. coli 212 and P. aeruginosa for our analysis, which amino acid sequences of the three conserved 213 PBP3 domains were identical to those of H. influenzae, except for one conservative amino 214 acid substitution in P. aeruginosa, where serine is replaced by threonine in the (K/H) (S/T)G 215 motif. The overall PBP3 amino acid sequence identity between H. influenzae and E. coli is 216 54%, between H. influenzae and P. aeruginosa 39%, and between E. coli and P. aeruginosa 217 47%. These identities are sufficient for our analysis, because we are interested in the 218 position of mutations in the three-dimensional structure and protein structure is more 219 conserved than protein sequence (32, 34). Crystal structure alignment of PBP3 of E. coli and 220 P. aeruginosa confirmed this statetement: the RMSD (Root Mean Square Deviation) of the 221 alignment of all matched atoms is 1.166 Å (see Figure 2a ), which stands for a good 222 accordance (32). Because the P. aeruginosa crystal structure (PDB ID code 3PBR) contains 223 a representation of the binding of beta-lactam meropenem and has a high resolution (1.95 224 Å), we used this structure to model the amino acid substitutions in H. influenzae. 225
Interestingly, all relevant amino acids were identical between the two strains, i.e. the amino 226 acids that we found to be directly or indirectly affected by the group-specific mutations 227 Arg517His, Asn526Lys, and Val547Ile (Figure S3 ). 228 Figure 2b shows the location of the conserved catalytic domains of the beta-lactam binding 229 site. None of the found mutations were directly located at the binding site but all substitutions 230 of group M were distant from the beta-lactam binding site, whereas group I and II 231 substitutions were closer to the binding site (Figure 2c) . 232
The amino acid substitution Val547Ile were found in almost all group M strains and some 233 group II strains (see Table 2 ). This conservative mutation has most likely no impact on 234 protein structure: Val547 is located in a hydrophobic pocket where it is surrounded by 235 aliphatic amino acids except for Thr532 and Thr281 (Figure 2d ) the substitution of the 236 aliphatic amino acid valine by the aliphatic amino acid isoleucine has most likely no influence 237 on the protein structure. 238
The amino acid substitution Arg517His occured in group I strains, and the substitution 239
Asn526Lys occurred in group II strains. These substitutions are adjacent and lie in 240 neighboring beta turns of the beta sheet that harbours the KTG motif. We speculate that 241
Arg517 and Asn526 are part of an important Arg517-Asn526-Glu324 interaction (Figure 2e , 242 left panel) for the following reasons: (a) Arg517 and Asn526 are able to build a hydrogen 243 bond and to connect the two beta turns, thus stabilizing this important region; (b) Arg517 is 244 able to build a hydrogen bond to Glu324, thus connecting the alpha helix that harbours the 245 STVK motif to the beta sheet that harbors the KTG motif. In addition, the positive charge of 246 arginine and the negative charge of glutamate attract each other. These interactions between 247 Arg517, Asn526 and Glu324 could stabilize the configuration of the two functional motifs 248 KTG and STVK. 249 As shown in the middle panel of Figure 2e , the group I mutation Arg517His results in the 250 loss of the electrostatic attraction to Glu324; His517 is able to replace Arg517 as a proton 251 acceptor in the hydrogen bond to Asn526, and can serve as a proton donor in the hydrogen 252 bond to Glu324. Yet, this substition might impact the protein structure, because (a) hydrogen 253 bonds are weaker than electrostatic interactions, and (b) histidine is less flexible than 254 arginine, which means that the Arg517-His517-Glu324 interaction has less degrees of 255 freedom than the Arg517-Asn526-Glu324 bridge. 256
As shown in the right panel of Figure 2e , the group II mutation Asn526Lys results in the loss 257 of the hydrogen bond to Arg517. In addition, lysine is negatively charged such as arginine, 258 which leads to an electrostatic repulsion. As a result, the two beta turns might now be 259 repelled from each other instead of attracted. 260 261
Genotypic and phenotypic detection of beta-lactamase production 262
In 25% of the isolates tested (13/53), beta-lactamase was detected by Cefinase TM test. The 263 same 13 strains were also found positive with TEM-1 PCR, and the remaining 40 strains 264 were TEM-1 negative ( Table 2) . 265 266
Susceptibility according to four aminopenicillin susceptibility groups 267
Based on the MIC distributions, results of benzylpenicillin disc screen and conclusions drawn 268 from the crystal structure binding sites, group M isolates were considered to belong either to 269 gBLNAS or gBLPAR, while group I and II isolates were considered to belong to gBLNAR or 270 gBLPACR. The classification of the investigated strains according to beta-lactamase 271 production and amino acid substitution groups is as follows: 36% (19/53) gBLNAS, 39% 272 (21/53) gBLNAR, 21% (11/53) gBLPAR and 4% (2/53) gBLPACR. The results of MIC testing 273 according to four aminopenicillin susceptibility groups is shown in Table 4 ). The number of gBLPACR strains in the study was only two, and therefore no 279 reliable classification according to susceptibility phenotype could be made for this group. 280 281
Discussion
282
In recent years, alterations in PBP3 leading to decreased binding affinity of certain beta-283 lactam antibiotics have emerged as a prevalent resistance mechanism in H. influenzae (35). 284 In this study, we investigated the mutations in the ftsI gene encoding for PBP3 within a 285 collection of clinical isolates from two Swiss hospitals. To our knowledge, our study 286 investigated for the first time the location and potential impact of the polymorphisms in the 287 PBP3 crystal structure of clinical isolates of H. influenzae with a detailed description of amino 288 acid interactions. The most frequently found group of amino acid substitutions belonged to 289 group II (19/53; 35.8%), which was also observed in studies from other European countries 290 (3, 14, 20, 21, 36) . We could not detect strains of the group III, which harbours high-level 291 PBP3 alterations (11, 35) . 292
All wild type strains showed MICs within the susceptible range for all tested antimicrobials 293 and were categorized as beta-lactam susceptible with benzylpenicillin disc screen, except, as 294 anticipated, beta-lactamase producing isolates. Surprisingly, the same results were obtained 295 for strains with amino acid substitutions of the group M (see Figure 1) . Based on our crystal 296 structure analysis, we suggest that the group I and group II substitutions Arg517His and 297
Asn526Lys influence the binding of beta-lactam antimicrobials trough a common mechanism 298 by disrupting the Asn526-Arg517-Glu324 interaction (see Figure 2e ). Since these three 299 amino acids are able connect the beta sheet and the alpha helix that harbour the KTG and 300 STVK motifs, their interaction might be important for a proper binding site formation. Further 301 molecular investigations including site-directed mutagenesis of these amino acids are clearly 302 needed to test this hypothesis. Interestingly, a just recently published study on the crystal 303 structure of H. influenzae comes to a similar conclusion that mutations Arg517His and 304
Asn526Lys might lead to resistance through long-range structural rearrangements (37). Our 305 study complements this finding and proposes a mechanistic explanation, i.e. the disruption of 306 the Asn526-Arg517-Glu324 bridge. 307
Group M substitutions are distant to the binding site and shown in Figure 4 and have 308 probably no influence on the configuration of the binding site. We propose, that strains 309 belonging to group M are phenotypically equal to the wild type, since an impact on the beta-310 lactam binding site is unlikely. This was confirmed by low MICs in antimicrobial susceptibility 311 testing of these isolates (Figure 1) and categorization as beta-lactam susceptible in 312 benzylpenicillin disc screen (Figure S2) . 313
Investigation of group III alterations (even though not found in this study) based on PBP3 314 structure of P. aeruginosa was not possible due to differences in amino acid sequences 315 between P. aeruginosa and H. influenzae in this region. 316
Although Ellington et al. concluded that prediction of antimicrobial resistance based on whole 317 genome sequencing data is currently not feasible and requires collection of extensive data 318 sets (38), the mechanistic understanding on how single point mutations impact binding 319 affinities of antibiotic drugs may help to predict antimicrobial resistance in the future. 320
All isolates in this study showed very low MICs to piperacillin-tazobactam (range <0.016-0.25 321 mg/l), which was also documented in european and asian studies (14, 39) . Piperacillin MICs 322 were also very low in non-beta-lactamase-producing strains (range <0.016-0.25 mg/l), which 323
implicates that there is no intrinsic activity of tazobactam against Haemophilus strains. 324
Nevertheless, no EUCAST nor CLSI breakpoints for H. influenzae have been issued to date 325 for piperacillin, and only CLSI breakpoints for piperacillin-tazobactam have been published 326 (29). 327 328 Reliable detection of beta-lactam resistance in H. influenzae is essential, since beta-lactam 329 antimicrobials represent a first line treatment for infections caused by this bacterium. 330
Detection of H. influenzae strains producing beta-lactamase with nitrocefin-based tests is 331 rapid and reliable. In 34 out of 36 isolates with PBP3 alterations, EUCAST screening for 332 beta-lactam susceptibility with benzylpenicillin disc was able to separate between PBP3 333 alterations with no impact on the beta-lactam binding (group M) and the alterations leading to 334 decreased affinity to beta-lactams (group I and II). All isolates containing amino acid 335 substitutions of group M were categorized as beta-lactam susceptible (showing zone 336 diameters of 15 to 19 mm), together with wild type isolates (exception: beta-lactamase 337 producing strains) as shown in Figure S2 . Two isolates belonging to groups I and II were 338 falsely categorized in screening as beta-lactam susceptible, but it needs to be mentioned that 339 they both exhibited zone diameter on the breakpoint (12 mm), and that technical factors 340 could be responsible for this borderline zone diameter. Further studies on larger collection of 341 clinical isolates are needed to investigate this observation. Furthermore, our study showed 342 that some gBLNAR strains (belonging to group I and II) are categorized as susceptible for 343 amoxicillin, ampicillin and amoxicillin-clavulanic acid when applying EUCAST interpretation 344 criteria ( Table 4) heteroresistance depends on a combination of altered PBP3, slowed drug influx and its 356 enhanced efflux due to the loss of regulation of the efflux pump (33). In the present study, we 357 found that 15% of BLNAR strains were categorized as meropenem intermediate when 358
interpreted with EUCAST meningitis breakpoints ( Table 4 ). In contrast, meropenem resistant 359 isolates were reported in the 7.4% of the gBLNAR isolates from a Portugese study (21). The 360 same study showed that the MIC50 and MIC90 values of meropenem were both four times 361 higher for gBLNAR isolates compared to gBLNAS. The same pattern was also observed for 362 the strains of this study, but no strains with resistant phenotype were observed ( Table 4) . 363
364
Our study has the following limitations: (a) the number of isolates examined in this study is 365 limited, but the results are in accordance with the findings of other Swiss and European 366 studies (3, 5, 14, 17) ; (b) no group III or group III-like isolates were included in the analysis, 367 since these isolates are still rarely found in Europe (3, 14, 17) ; (c) besides the heterogenous 368 impact of various alterations in PBP3 with multiple changes in amino acids also other 369 possible resistance mechanisms like efflux pumps might further act on the MICs of 370 antimicrobials (17, 33, 40) . 371
372
In conclusion, based on our molecular and phenotypic findings, we assume that strains 373 belonging to M group are phenotypically equal to wild type, while amino acid substitutions of 374 group I and group II affect the beta-lactam binding through a common mechanism by 375 disrupting the Asn526-Arg517-Glu324 interaction. Not all PBP3 alterations have an influence 376 on the resistant phenotype in H. influenzae. When EUCAST interpretation criteria were 377 applied, some gBLNAR strains (all harbouring group I and II mutations) were categorized as 378 susceptible to ampicillin, amoxicillin or amoxicillin-clavulanic acid. 
Fig. S3
Protein sequence of the reference strain H. influenzae RD KW20 (UniProt Entry P45059). The group-specific amino acid substitutions Arg517His, Asn526Lys and Val547Ile are shown in green and their suggested interaction partners Arg517 and Glu324 are highlighted in yellow. The three motifs that define that active site of the serine penicillin-recognizing enzyme family are shown in blue, purple and red. The amino acid substitution Arg517His were found in all group I strains and might lead to a loss of an electrostatic interaction to Glu324. Substitution Asn526Lys were found in all group II strains and might lead to a loss of a hydrogen bond to Arg517. Substitution Val547Ile were found in all group M and in some group II strains and has most likely no impact on the protein structure. For more information on the identified mutations, see Table 1 . For a representation of the mutations in the three-dimensional protein structure, see Figures 4-6. Amino acids in grey belong to a beta-loop that is not represented in the crystal structure that was used for structure analysis (PDB ID 3PBR).
